# Ndufs4−/− mice: a testing ground for longevity interventions

**Authors:** Jackson Nuss, Matt Kaeberlein, Alessandro Bitto, Anthony S. Grillo

PMC · DOI: 10.1007/s11357-025-01704-8 · GeroScience · 2025-06-05

## TL;DR

This paper explores how a mouse model of Leigh syndrome can help test longevity interventions and reveals sex-specific differences in disease progression and lifespan.

## Contribution

The study identifies sex-specific resilience and the effectiveness of 17-alpha-estradiol in extending lifespan in a mitochondrial disease model.

## Key findings

- Female Ndufs4−/− mice show increased resilience with longer lifespans despite similar disease onset.
- 17-alpha-estradiol treatment delays disease symptoms and extends lifespan in these mice.
- Clasping onset correlates with survival, and weight correlates with lifespan in females.

## Abstract

Mice missing the complex I subunit Ndufs4 of the electron transport chain are widely used as a leading animal model of Leigh syndrome, a pediatric neurodegenerative disorder that leads to premature death. More broadly, this animal model has enabled a better understanding of the pathophysiology of mitochondrial disease and mitochondrial dysfunction in sporadic disorders. Intriguingly, longevity interventions are very effective at treating symptoms of disease in this model. Herein, we introduce the model and its notable features that may help provide insights in longevity research. We performed a retrospective analysis of historical data from our laboratories over the past 10 years regarding the use of this animal model in aging studies, the manifestation and progression of mitochondrial disease, and factors that influence their premature death. We observed a correlation between weight and lifespan in female animals and a sex-independent correlation between the onset of clasping, a typical neurodegenerative symptom, and overall survival. We observed a sexual dimorphism in lifespan with female mice being more resilient despite a similar age of onset of disease symptoms. Lastly, we report increased lifespan and delayed onset of disease symptoms following treatment with 17-alpha-estradiol, a non-feminizing estrogen which can extend lifespan in genetically heterogeneous mice. This analysis serves as a useful guide for researchers utilizing this animal in the discovery of effective interventions for longevity and to prevent the onset of disease. It suggests there may be unprecedented underlying sex-specific differences in patients with Leigh syndrome and further strengthens the connection between normative aging and mitochondrial dysfunction.

The online version contains supplementary material available at 10.1007/s11357-025-01704-8.

## Linked entities

- **Genes:** NDUFS4 (NADH:ubiquinone oxidoreductase subunit S4) [NCBI Gene 4724]
- **Chemicals:** 17-alpha-estradiol (PubChem CID 68570)
- **Diseases:** Leigh syndrome (MONDO:0009723), mitochondrial disease (MONDO:0004069)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ndufs4 (NADH:ubiquinone oxidoreductase core subunit S4) [NCBI Gene 17993] {aka 6720411N02Rik, C1-18k}
- **Diseases:** sporadic disorders (MESH:D020821), mitochondrial disease (MESH:D028361), Leigh syndrome (MESH:D007888), neurodegenerative disorder (MESH:D019636), premature death (MESH:D003643)
- **Chemicals:** 17-alpha-estradiol (MESH:C519808)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12634981/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12634981/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12634981/full.md

---
Source: https://tomesphere.com/paper/PMC12634981